Soluble CD23 and interleukin-1 receptor antagonist in human asthmatics following antigen challenge

Journal of Asthma

Volumn 42, Issue 1, 2005, Pages 73-76

  Amrol, David J ^a,b   Hagaman, David D ^a   Sheller, James R ^a   Murray, John J ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Bronchoalveolar lavage; CD23; IL 1ra; Low affinity IgE receptor; Segmental antigen challenge

Indexed keywords

BECLOMETASONE; BRONCHODILATING AGENT; CD23 ANTIGEN; CORTICOSTEROID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PLACEBO;

ADULT; ARTICLE; ASTHMA; BRONCHOSCOPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA; BECLOMETHASONE; BRONCHIAL PROVOCATION TESTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, IGE; RECEPTORS, INTERLEUKIN-1;

EID: 14944342689     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1081/JAS-200044761     Document Type: Article

References (27)

1. Yokota A, Kikutani H, Tanaka T, Sato R, Barsmian EL, Suemura M, et al. Two species of human Fce receptor II: tissue specific and IL-4 specific regulation of gene expression. Cell 1998; 55:611-618.
2. Armitage R, Goff L, Beverly P. Expression and function al role of CD23 on T cells. Eur J Immunol 1989; 19:31-35.
3. Conrad D. Fc epsilon RII: the low affinity receptor for IgE. Annu Rev Immunol 1990; 8:623-645.
4. Campbell A, Vignola A, Chanez P, Godard P, Bousquet J. Low affinitry receptor for IgE on human bronchial epithelial cells in asthma. Immunology 1994; 82:506-508.
5. Matz J, Williams J, Rosenwasser L, Borish L. GMCSF stimulates macrophages to respond to IgE via CD23. J Allergy Clin Immunol 1994; 93:650-657.
6. Vercelli D, Jabara H, Lee B, Woodland N, Geha R, Leung D. Human IL-4 induces CD23 on normal human monocytes. J Exp Med 1998; 167:1406-1416.
7. Rosenwasser L, Bussee W, Lizambri R, Olejnik T, Totoritis M. Allergic asthma and an anti-CD23 mAb: results of a phase I, single-dose, dose escalating clinical trial. J Allergy Clin Immunol 2003; 112:563-570.
8. Sabbah A, Buchmann C, Lauret MG, Drouet M. Correlational study between lymphocyte IgE markers: membrane CD23 (mCD23) and soluble CD23 (sCD23) in an atopic population. Allergy Immunol (Paris) 1993; 25(2):48-54.
9. Aberle N, Gagro A, Rabatic S, Reiner-Banovac Z, Dekaris D. Expression of CD23 and its ligands in children with intrinsic and extrinsic asthma. Allergy 1997; 52:1238-1242.
10. Ten R, McKinstry M, Bren G, Paya C. Signal transduction pathways triggered by CD23 in human monocytes leads to NF-kB activation. J Allergy Clin Immunol 1999; 104:376-387.
11. Lantero S, Alessandri G, Spallarossa L, Rossi G. Stimulation of eosinophil CD23 leads to increased adhesion molecule expression and cell migration. Eur Respir J 2000; 16:940-946.
12. H2 environment. Ann Allergy Asthma & Immun 2003; 91:567-574.
13. Cernadas M, De Sanctis G, Krinzman D, Mark C, Donovan J, Listman L, Kobzik H, et al. CD23 and allergic pulmonary inflammation: potential role as an inhibitor. Am J Respir Cell Mol Biol 1999; 20:1-8.
14. Hackzy A, Takeda K, Hamelmann E, Loader J, Joetham A, Redai I, et al. CD23 exhibits negative regulatory effects of allergic sensitization and airway hyperresponsiveness. Am J Respir Crit Care Med 2000; 161:952-960.
15. Riffo-Vasquez Y, Spina D, Thomas M, Bilbert T, Gilbey T, et al. The role of CD23 on allergen-induced IgE levels, pulmonary eosinophilia and bronchial hyperresponsiveness in mice. Clin Exp Allergy 2000; 30:728-738.
16. Duggas N, Vouldoukis I, Becherel P, Arock M, Debre P, et al. Triggering of CD23b antigen by CD23 monoclonal ab induces IL-10 production by human macrophages. Eur J Immunol 1996; 26:1394-1398.
17. Dinarello C, Wolff S. The role of IL-1 in disease. N Engl J Med 1993; 328:106-113.
18. Broide D, Lotz M, Cuomo A, Coburn D, Federman E, Wasserman S. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992; 89:958-967.
19. Hagaman D, Okayama Y, D'Ambrosio C, Prussin C, Gilfillan AM, Metcalfe DD. Secretion of Interleukin-1 Receptor Antagonist from Human Mast Cells after Immunoglobulin E-Mediated Activation and after Segmental Antigen Challenge. Am J Respir Cell Mol Biol 2001; 25:685-691.
20. Tsukagoshi H, Sakamoto T, Xu W, Barnes P, Chung K. Effect of IL-1 on airway hyperresponsiveness and inflammation in sensitized and non-sensitized Brown-Norway rats. J Allergy Clin Immunol 1994; 93:464-469.
21. Arend W, Malyak A, Guthridge C, Gabay C. IL-1 ra: role in biology. Annu Rev Immunol 1998; 16:27-55.
22. Chung K, Barnes P. Cytokines in asthma. Thorax 1999; 54(9):825-857.
23. Watson M, Smith D, Bourne A, Thompson R, Westwick J. Cytokines contribute to airway dysfunction in guinea pigs: inhibition of AHR, eosinophil accumulation, and TNF generation by pretreatment with an IL-1ra. Am J Respir Cell Mol Biol 1993; 8:365-369.
24. Sousa A, Trigg C, Lane S, et al. Effect of inhaled glucocorticoids on IL-1 beta and IL1-ra expression in asthmatic bronchial epithelium. Thorax 1997; 52:407-410.
25. Schiff M. Role of IL-1 and IL-1ra in the mediation of rheumatoid arthritis. Ann Rheum Dis 2000; 59(Suppl):103-108.
26. Busse W, Rosenwasser L, Lizambri R, Olejnik T, Totortis M. Results of phase I, single-dose, dose-escalating trial of a primatized anti-CD23 monoclonal antibody (IDEC-152) in patients with allergic asthma. J Allergy Clin Immunol 2001; 107:S106.
27. Sarfati M, Bettler B, Letellier M, et al. Native and recombinant soluble CD23 fragments with IgE suppressive activity. Immunology 1992; 76:662-667.